Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancer.
| Autor: | Laskin JJ, Nicholas G, Lee C, Gitlitz B, Vincent M, Cormier Y, Stephenson J, Ung Y, Sanborn R, Pressnail B, Nugent F, Nemunaitis J, Gleave ME, Murray N, Hao D |
|---|---|
| Zdroj: | Journal of Thoracic Oncology; 2012 Mar, Vol. 7 Issue 3, p579-586, 8p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|